Mark Hughes, NP
Adult Health · Norwell, MANPI 1205412863
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 49.2% of the total. Among adult health clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $22.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- E.r. Squibb & Sons, L.L.C.$364
- Johnson & Johnson$299
- Novartis$266
- LEO Pharma Inc.$250
- UCB, Inc.$97
- plus $338 from 7 others
What the payments were for
- Food & beverage$2,98194%
- Education$1996%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $1,566 |
| E.r. Squibb & Sons, L.L.C. | 21 | $364 |
| Johnson & Johnson | 9 | $299 |
| Novartis | 12 | $266 |
| LEO Pharma Inc. | 9 | $250 |
| UCB, Inc. | 6 | $97 |
| Lilly USA, LLC | 3 | $79 |
| Incyte Corporation | 3 | $73 |
| Sanofi | 2 | $54 |
| Sun Pharmaceutical Industries Inc. | 3 | $46 |
| Organon | 1 | $35 |
| Amgen | 1 | $34 |
| Galderma Laboratories, L.p. | 1 | $16 |
How this compares
$3,180 in reported general payments places this provider in the 90th percentile of 671 adult health providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 16 | $1,363 |
| Triamcinolone Acetonide | 63 | $1,255 |
| Ketoconazole | 46 | $825 |
| Doxycycline Hyclate | 12 | $175 |
Paid to pharmacies, not to this prescriber.
Other adult health in Norwell
- Krista TuckerBoston$157K
- Kathleen Dietz LovettHyannis$123K
- Caitlin ReenCharlestown$89K
- Tiffini ReedyFall River$58K
- Christine AgiusBoston$32K
- Amy PierreJamaica Plain$27K
- Josie BazemoreBoston$22K
- Jill TerrienWorcester$18K
- Beverly HarrisGroton$15K
- Kelly GoodwinFranklin$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.